Arkolith/Insider Trading/CMMB/Form 4

Marvin Donald

Executive VP, CFO & COOChemomab Therapeutics Ltd. (CMMB) · full profile →Form 4 · filed Jun 21, 2022
Net Buying
Open-Market Buys
$2K
Open-Market Sells
$0
Net Open-Market Flow
$2K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2022Buy(P)250$3.30$8252K
Mar 16, 2022Buy(P)250$3.25$8132K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 8, 2021Grant(A)197K—$0197K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-22-002402) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML